| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.78T | 1.81T | 1.75T | 1.88T | 1.61T | 1.21T |
| Gross Profit | 382.25B | 388.29B | 370.80B | 381.49B | 378.74B | 293.84B |
| EBITDA | 153.46B | 186.12B | 183.24B | 197.27B | 204.58B | 150.44B |
| Net Income | 15.08B | 32.24B | 50.00B | 82.94B | 109.99B | 57.87B |
Balance Sheet | ||||||
| Total Assets | 2.11T | 2.15T | 2.22T | 2.07T | 1.93T | 1.56T |
| Cash, Cash Equivalents and Short-Term Investments | 180.51B | 209.23B | 210.29B | 186.31B | 181.15B | 195.99B |
| Total Debt | 749.27B | 737.98B | 756.76B | 738.25B | 666.09B | 510.22B |
| Total Liabilities | 1.15T | 1.18T | 1.23T | 1.18T | 1.13T | 875.97B |
| Stockholders Equity | 829.90B | 848.28B | 862.85B | 786.83B | 712.65B | 607.92B |
Cash Flow | ||||||
| Free Cash Flow | 89.48B | 62.09B | 7.35B | -36.62B | -23.63B | 97.74B |
| Operating Cash Flow | 206.13B | 200.50B | 161.34B | 101.24B | 92.58B | 174.32B |
| Investing Cash Flow | -165.79B | -165.01B | -123.94B | -106.34B | -205.23B | -77.56B |
| Financing Cash Flow | -72.13B | -74.44B | -26.02B | 2.54B | 89.22B | -68.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $352.46B | 8.37 | 9.34% | 4.53% | -0.48% | -35.29% | |
77 Outperform | $549.88B | 13.28 | 6.42% | 3.46% | -6.27% | 40.98% | |
77 Outperform | ¥692.11B | 19.66 | 12.15% | 1.62% | 2.62% | 2.81% | |
74 Outperform | $269.84B | 11.91 | 4.90% | 3.49% | 3.80% | -11.14% | |
62 Neutral | $693.99B | 45.90 | 1.78% | 4.16% | -0.91% | -74.07% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | $1.03T | 30.03 | 3.63% | 4.09% | -1.17% | ― |
Mitsui Chemicals has completed the payment procedures for the disposal of treasury shares under its Restricted Stock Incentive Plan for the Employee Shareholding Association. The number of shares and total disposal amount were adjusted due to partial forfeiture of rights, reflecting the number of members agreeing to the plan.
The most recent analyst rating on (JP:4183) stock is a Hold with a Yen3954.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.
Mitsui Chemicals, Inc., a prominent player in the chemical industry, specializes in the production of a wide range of chemical products, including life and healthcare solutions, mobility solutions, ICT solutions, and basic and green materials. The company has a strong presence in both domestic and international markets, with a focus on innovation and sustainability.
Mitsui Chemicals reported a decline in sales revenue and operating income for the first quarter of FY2025 compared to the previous year, with notable decreases in the Basic & Green Materials segment. Despite the organizational reforms and segment revisions, the company faces challenges in maintaining profitability amidst fluctuating exchange rates and naphtha prices, impacting its financial performance and market positioning.
The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.